Editor Brian Harrod Provides Comprehensive up-to-date news coverage, with aggregated news from sources all over the world from the Roundup Newswires Network
In this Thursday, Aug. 17, 2017, file photo, Sen. Bob Menendez, D-N.J., speaks during a news conference, in Union Beach, N.J. Opening statements are scheduled for Wednesday, Sept. 6, in the trial of Menendez and Florida ophthalmologist, Dr. Salomon Melgen.
In this Thursday, Aug. 17, 2017, file photo, Sen. Bob Menendez, D-N.J., speaks during a news conference, in Union Beach, N.J. Opening statements are scheduled for Wednesday, Sept. 6, in the trial of Menendez and Florida ophthalmologist, Dr. Salomon Melgen.
BioTime, Inc. , a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that it will be presenting one podium presentation and two abstracts at the Military Health System Research Symposium August 27-30, 2017 in Washington, D.C. BioTime has recently released data from its two lead programs in medical aesthetics and ophthalmology and is now exploring ways to address serious unmet needs for trauma and combat-related injuries.